Skip to content
Home
About us
Team
Investments
Investor Relations
Sustainability
News
Meet us
align-justify
Home
About us
Team
Investments
Investor Relations
Sustainability
News
Meet us
user-group
INVESTOR ACCESS
Search
apps
Home
About us
Team
Investments
Investor Relations
Sustainability
News
Meet us
Home
/
Venture Capital
/
MRM Health Reports Preclinical...
Venture Capital
MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis
6 June 2022
Download
Press Release
Download
Related News
Other news
April 1, 2026
Mérieux Equity Partners announces the appointment of Quentin de Labarre to Partner, along with several other promotions across the firm
arrow-up-right
Buyout
Buyout
February 12, 2026
Mérieux Equity Partners acquires a significant minority stake in Health in Code
arrow-up-right
Buyout
Buyout
December 15, 2025
Mérieux Equity Partners Announces Agreement to Sell Majority of its Stake in Swixx Biopharma.
arrow-up-right
